RH&P Global Life Sciences Fund A CAP USD

Reference Data

ISIN LU0115986761
Valor Number 1113164
Bloomberg Global ID
Fund Name RH&P Global Life Sciences Fund A CAP USD
Fund Provider RH&PARTNER Investment Funds Basel, Switzerland
Phone: +41 61 378 83 63
E-Mail: info@rh-finanz.ch
Web: https://www.rh-finanz.ch
Fund Provider RH&PARTNER Investment Funds
Representative in Switzerland ACOLIN Fund Services AG
Zürich
Phone: +41 44 396 96 96
Distributor(s) Banque Pictet & Cie SA Credit Suisse
Zürich UBS
n/a Vontobel
n/a
Asset Class Equities
EFC Category Equity Health Care
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel)
Redemption Condition The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel)
Investment Strategy *** N/A
Peculiarities

Fund Prices

Current Price * 205.30 USD 20.01.2026
Previous Price * 205.22 USD 19.01.2026
52 Week High * 217.04 USD 27.11.2025
52 Week Low * 152.05 USD 08.04.2025
NAV * 205.30 USD 20.01.2026
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 67,540,457
Unit/Share Assets *** 62,928,740
Trading Information SIX

Performance

YTD Performance -0.53% 31.12.2025
20.01.2026
YTD Performance (in CHF) -0.91% 31.12.2025
20.01.2026
1 month -4.74% 22.12.2025
20.01.2026
3 months +7.43% 20.10.2025
20.01.2026
6 months +23.53% 21.07.2025
20.01.2026
1 year +16.59% 20.01.2025
20.01.2026
2 years +25.36% 22.01.2024
20.01.2026
3 years +14.71% 20.01.2023
20.01.2026
5 years -3.32% 20.01.2021
20.01.2026

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Charles River Laboratories International Inc 4.53%
Bio-Techne Corp 4.46%
Nektar Therapeutics 4.36%
Illumina Inc 3.93%
Exelixis Inc 3.87%
Alkermes PLC 3.72%
IQVIA Holdings Inc 3.65%
Biogen Inc 3.59%
Amgen Inc 3.57%
Incyte Corp 3.53%
Last data update 30.04.2021

Cost / Risk

TER *** 2.431%
TER date *** 30.11.2025
Performance Fee ***
PTR
Max. Management Fee *** 1.40%
Ongoing Charges *** 2.43%
SRRI ***
SRRI date *** 31.12.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)